Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
Status:
Withdrawn
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Retinal Vein Occlusion is a blockage of the blood vessels that drain out of the retina.
Complications of retinal vein occlusion which threaten vision include
neovascularization(growth of new blood vessels)and macular edema ( accumulation of fluid
"leaking" from abnormal blood vessels). Currently, the treatment of retinal vein occlusion is
laser photocoagulation. This treatment has found to have limited use in this type of
condition.Anecortave Acetate is being considered as an attempt to control the growth of the
abnormal blood vessels.